Article
Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation
14 Nov 2011
Abstract excerpt
Pancreatic β-cells are an essential source of insulin and their destruction because of autoimmunity causes type I diabetes. We conducted a chemical screen to identify compounds that would induce the differentiation of insulin-producing β-cells in vivo. To do this screen, we brought together the use of transgenic zebrafish as a model of β-cell differentiation, a unique multiwell plate that allows easy...
